Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination



Rating:

Share or cite this content

Citations should be made in the following way:
D. Goletti (Rome, Italy). IGRA testing to diagnose TB disease and infection. What is new in clinical practice and for programmatic management. School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination

Member's Comments

No comment yet.

Related content which might interest you: An evaluation framework for new tests that predict progression from tuberculosis infection to clinical disease Source: Eur Respir J, 52 (4) 1800946; 10.1183/13993003.00946-2018 Year: 2018 The ERS-endorsed official ATS/CDC/IDSA clinical practice guidelines on treatment of drug-susceptible tuberculosis Source: Eur Respir J 2016; 48: 963-971 Year: 2016 Non-tuberculous mycobacterial disease in patients who were referred as MDR-TB in resource limited settings: need for more rapid identification Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2008 Immunological response in HIV-associated tuberculosis and the implications of HIV in the search for a tuberculosis vaccine Source: Annual Congress 2007 - Tuberculosis control and HIV in Europe: good or bad news? Year: 2007 Improved diagnostic evaluation of suspected tuberculosis in routine practice Source: Annual Congress 2008 - New tools in tuberculosis diagnosis Year: 2008 Low real-world utility of IGRA when screening for LTBI in a low incidence setting Source: International Congress 2015 – Screening strategies in TB Year: 2015 HIV co-infection excludes many drug-resistant tuberculosis patients from clinical trials with novel antituberculosis drugs Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 From patients to research laboratories and back: overview of the major scientific achievements and their impact in TB diagnosis, clinical management and control Source: Annual Congress 2013 –The best of TB PANNET Year: 2013 WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update Source: Eur Respir J 2011; 38: 516-528 Year: 2011 Effectiveness of TB diagnostics with microbiological methods in TB service and general health care institutions Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis Year: 2011 Therapeutic drug monitoring practice in patients with active tuberculosis: assessment of opportunities Source: Eur Respir J, 57 (1) 2002349; 10.1183/13993003.02349-2020 Year: 2021 Advancing global programmatic management of latent tuberculosis infection for at risk populations Source: Eur Respir J 2016; 47:1327-1330 Year: 2016 Innovative tools for diagnosis and prevention of paediatric tuberculosis Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis Year: 2019 The standardised treatment of pulmonary TB: outcomes, problems and suggestions Source: Annual Congress 2005 - PG10 - The management of tuberculosis: tradition and novelties Year: 2005 Use of molecular-genetic methods in diagnostics and therapy of a tuberculosis (TB) at patients with HIV Source: Annual Congress 2010 - Tuberculosis in special populations Year: 2010 Clinical management of LTBI (PDF)// IGRAs for the diagnosis of tuberculosis (PPT) Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination Year: 2012